Verge Genomics is transforming drug development for neurodegenerative diseases through its AI-powered platform that integrates human tissue data, machine learning, and computational biology. The platform's algorithms analyze gene expression patterns, predict therapeutic targets, and optimize compound selection for neurological disorders. Verge Genomics collaborates with pharmaceutical companies, research institutions, and healthcare organizations, advancing projects in Alzheimer's, Parkinson's, and ALS. With robust data security, scalable infrastructure, and continuous innovation, Verge Genomics is shaping the future of neuroscience drug discovery. SEO keywords: "Verge Genomics AI drug discovery," "AI neurodegenerative platform," "human tissue drug development," "AI neurological therapeutics," "Verge Genomics innovation."